Chronic Lymphocytic Leukaemia (CLL) — MRCP Part 1 MCQ

Instant feedback + full explanation. One question, done properly.

HardHaematology & OncologyChronic Lymphocytic Leukaemia (CLL)mrcp part 1

A 67-year-old man with chronic lymphocytic leukaemia (CLL) has progressive disease. According to NICE, which targeted therapy is approved for first-line treatment in symptomatic CLL if there are adverse prognostic markers?

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.

Chronic Lymphocytic Leukaemia (CLL) — MRCP Part 1 MCQ | iatroX